Safety and Tolerability of extended-release Acetylsalicylic Acid Capsules: A Summary of double-blind Comparative Studies

References

• Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists’ Collaboration . BMJ308 ( 6921 ), 81 – 106 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Vandvik PO , LincoffAM, GoreJMet al. Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th Edition: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines . Chest141 ( Suppl. 2 ), e637S – e668S ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Furie KL , KasnerSE, AdamsRJet al. American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association . Stroke42 ( 1 ), 227 – 276 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Patrono C . Aspirin as an antiplatelet drug . N. Engl. J. Med330 ( 18 ), 1287 – 1294 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Patrono C , García RodríguezLA, LandolfiR, BaigentC . Low-dose aspirin for the prevention of atherothrombosis . N. Engl. J. Med.353 ( 22 ), 2373 – 2383 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Ricciotti E , FitzgeraldGA . Prostaglandins and inflammation . Arterioscler. Thromb. Vasc. Biol.31 ( 5 ), 986 – 1000 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wallace JL . Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn’t the stomach digest itself?Physiol. Rev.88 ( 4 ), 1547 – 1565 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Laine L , TakeuchiK, TarnawskiA . Gastric mucosal defense and cytoprotection: bench to bedside . Gastroenterology135 ( 1 ), 41 – 60 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Moncada S , VaneJR . Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls . N. Engl. J. Med.300 ( 20 ), 1142 – 1147 ( 1979 ).
   PubMed Web of Science ®Google Scholar
• Moncada S , WhittleBJ . Biological actions of prostacyclin and its pharmacological use in platelet studies . Adv. Exp. Med. Biol.192, 337 – 358 ( 1985 ).
   PubMed Web of Science ®Google Scholar
• Smyth EM , GrosserT, WangM, YuY, FitzgeraldGA . Prostanoids in health and disease . J. Lipid. Res.50 ( Suppl. ), S423 – S428 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Fetalvero KM , MartinKA, HwaJ . Cardioprotective prostacyclin signaling in vascular smooth muscle . Prostaglandins. Other Lipid Mediat.82 ( 1–4 ), 109 – 118 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Moncada S , GryglewskiR, BuntingS, VaneJR . An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation . Nature263 ( 5579 ), 663 – 665 ( 1976 ).
   PubMed Web of Science ®Google Scholar
• Graham DY , SmithJL . Aspirin and the stomach . Ann. Intern. Med.104 ( 3 ), 390 – 398 ( 1986 ).
   PubMed Web of Science ®Google Scholar
• Kelly JP , KaufmanDW, JurgelonJM, SheehanJ, KoffRS, ShapiroS . Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product . Lancet348 ( 9039 ), 1413 – 1416 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Awtry EH , LoscalzoJ . Aspirin . Circulation101 ( 10 ), 1206 – 1218 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Schnell O , ErbachM, HummelM . Primary and secondary prevention of cardiovascular disease in diabetes with aspirin . Diab. Vasc. Dis. Res.9 ( 4 ), 245 – 255 ( 2012 ).
   PubMedGoogle Scholar
• Capodanno D , PatelA, DharmashankarKet al. Pharmacodynamic effects of different aspirin dosing regimens in Type 2 diabetes mellitus patients with coronary artery disease . Circ. Cardiovasc. Interv.4 ( 2 ), 180 – 187 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Bonten TN , SarisA, van OostromMJet al. Effect of aspirin intake at bedtime versus on awakening on circadian rhythm of platelet reactivity. A randomised cross-over trial . Thromb. Haemost.112 ( 6 ), 1209 – 1218 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Gasparyan AY , WatsonT, LipGY . The role of aspirin in cardiovascular prevention: implications of aspirin resistance . J. Am. Coll. Cardiol.51 ( 19 ), 1829 – 1843 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Gurbel PA , BlidenKP, DiChiaraJet al. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study . Circulation115 ( 25 ), 3156 – 3164 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Rocca B , PatronoC . Determinants of the interindividual variability in response to antiplatelet drugs . J. Thromb. Haemost.3 ( 8 ), 1597 – 1602 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Grove EL , HvasAM, MortensenSB, LarsenSB, KristensenSD . Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease . J. Thromb. Haemost.9 ( 1 ), 185 – 191 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Grove EL , HvasAM, KristensenSD . Immature platelets in patients with acute coronary syndromes . Thromb. Haemost.101 ( 1 ), 151 – 156 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Simpson SH , AbdelmoneimAS, OmranD, FeatherstoneTR . Prevalence of high on-treatment platelet reactivity in diabetic patients treated with aspirin . Am. J. Med.127 ( 1 ), 95.e1 – 95.e9 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Watala C , GolanskiJ, PlutaJet al. Reduced sensitivity of platelets from Type 2 diabetic patients to acetylsalicylic acid (aspirin) – its relation to metabolic control . Thromb. Res.113 ( 2 ), 101 – 113 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Lordkipanidze M , HarrisonP . Aspirin twice a day keeps new COX-1 at bay . J. Thromb. Haemost.10 ( 7 ), 1217 – 1219 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Durlaza (aspirin) extended release capsules, for oral use [package insert] . New Haven Pharmaceuticals, Inc., North Haven, CT, USA ( 2015 ).
   Google Scholar
• Patrick J , DillahaL, ArmasD, SessaW . A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation . Postgrad. Med.127 ( 6 ), 573 – 580 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Brown N , MayJA, WilcoxRGet al. Comparison of antiplatelet activity of microencapsulated aspirin 162.5 mg (Caspac XL), with enteric coated aspirin 75 mg and 150 mg in patients with atherosclerosis . Br. J. Clin. Pharmacol.48 ( 1 ), 57 – 62 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Rocca B , SantilliF, PitoccoDet al. The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes . J. Thromb. Haemost.10 ( 7 ), 1220 – 1230 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bliden KP , PatrickJ, PennellAT, TantryUS, GurbelPA . Drug delivery and therapeutic impact of extended-release acetylsalicylic acid . Future Cardiol.12 ( 1 ), 45 – 58 ( 2015 ).
   PubMedGoogle Scholar
• Smith SC Jr , BenjaminEJ, BonowROet al. The World Heart Federation and the Preventive Cardiovascular Nurses Association. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation . Circulation124 ( 22 ), 2458 – 2473 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Coleman CI , LimoneB, SobierajDMet al. Dosing frequency and medication adherence in chronic disease . J. Manag. Care Pharm.18 ( 7 ), 527 – 539 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Srivastava K , AroraA, KatariaA, CappelleriJC, SadoskyA, PetersonAM . Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis . Patient Prefer. Adherence7, 419 – 434 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Derry S , LokeYK . Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis . BMJ321 ( 7270 ), 1183 – 1187 ( 2000 ).
   PubMed Web of Science ®Google Scholar